Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
1.
Neurochirurgie ; 48(2-3 Pt 2): 223-5, 2002 May.
Article in French | MEDLINE | ID: mdl-12058127

ABSTRACT

ACTH assay in cavernous sinus samples during resection of pituitary adrenocorticotroph adenomas is a simple and safe technique providing an intraoperative assessment of adrenocorticotroph hormone gradients. Bilateral puncture of the cavernous sinus can be achieved vial the standard transsphenoidal approach to the sella turcica. ACTH is determined with IRMA at 37;C with an incubation time of less than one hour. Among 71 cases in our experience, the ACTH gradient accurately predicted the position of the adenoma in 93% of the cases. This rate is higher than the 61% accuracy reported for inferior petrosal sinus sampling. The technique reported is more precise than MRI which correctly identifies adenomas in only 50% of the cases. The remaining cases are either false positives or false negatives. We report an 82% cure rate either via direct resection of the microadenoma or via partial hypophysectomy guided by the ACTH gradient. In our series, 20 cases of Cushing's disease had a normal MRI and no surgically identifiable adenoma. In 10 of these cases however, cure was achieved by performing ACTH gradient guided partial hypophysectomy. This method produces no morbidity and is most helpful for the neurosurgeon allowing confirmation of the position of an MRI-visible adenoma or an adenoma identified intraoperatively. It does not however replace neurosurgical experience which remains the most important predictive factor for outcome in surgical treatment of Cushing's disease.


Subject(s)
Adenoma/surgery , Adrenocorticotropic Hormone/blood , Cushing Syndrome/surgery , Hypophysectomy , Intraoperative Care/methods , Petrosal Sinus Sampling , Pituitary Neoplasms/surgery , Adenoma/complications , Adenoma/metabolism , Adenoma/pathology , Adrenocorticotropic Hormone/metabolism , Cushing Syndrome/etiology , Follow-Up Studies , Humans , Hypophysectomy/methods , Magnetic Resonance Imaging , Pituitary Neoplasms/complications , Pituitary Neoplasms/metabolism , Pituitary Neoplasms/pathology , Predictive Value of Tests , Radioimmunoassay , Retrospective Studies , Treatment Outcome
2.
Oncogene ; 20(41): 5810-7, 2001 Sep 13.
Article in English | MEDLINE | ID: mdl-11593386

ABSTRACT

Secreted Frizzled-related protein 1 (SFRP1) encodes a member of a protein family that contains a cysteine-rich domain similar to the WNT-binding site of Frizzled receptors and regulates the WNT pathway. The WNT pathway is frequently altered in human cancers. We have defined the pattern of SFRP1 mRNA expression in the progression of breast cancer. We show that SFRP1 is expressed in the epithelial component of normal breast, in the in situ component of ductal carcinomas and is lost in more than 80% of invasive breast carcinomas except the medullary type. Loss of SFRP1 expression is correlated with the presence of hormonal receptors. Conversely, the maintenance of SFRP1 in carcinomas is correlated with the presence of lymphoplasmocytic stroma. No significant association was observed between SFRP1 status and the level of apoptosis in tumoral cells.


Subject(s)
Breast Neoplasms/metabolism , Carcinoma in Situ/metabolism , Carcinoma, Ductal, Breast/metabolism , Carcinoma, Medullary/metabolism , Glycoproteins/metabolism , Neoplasm Proteins/metabolism , Proto-Oncogene Proteins/metabolism , Zebrafish Proteins , Adult , Aged , Aged, 80 and over , Apoptosis/physiology , Breast/metabolism , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Carcinoma in Situ/genetics , Carcinoma in Situ/pathology , Carcinoma, Ductal, Breast/genetics , Carcinoma, Ductal, Breast/pathology , Carcinoma, Medullary/genetics , Carcinoma, Medullary/pathology , Female , Gene Silencing , Glycoproteins/genetics , Humans , Intracellular Signaling Peptides and Proteins , Middle Aged , Neoplasm Proteins/genetics , RNA, Messenger/metabolism , Signal Transduction , Wnt Proteins
3.
J Clin Endocrinol Metab ; 85(11): 4060-8, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11095433

ABSTRACT

We present an in vivo and in vitro study of congenital adrenal hyperplasia in a patient with 11beta-hydroxylase deficiency. Sequencing of the CYP11B1 gene showed two new base substitutions, a conservative 954 G-->C transversion at the last base of exon 5 (T318T), and a IVS8 + 4A-->G transition in intron 8. In addition, two polymorphisms were found in exons 1 and 2. The genetically female patient was raised as a male because of severe pseudohermaphroditism. Glucocorticoid-suppressive treatment encountered difficulties in equilibration and compliance, resulting in uncontrolled hypertension with pronounced hypertrophic cardiomyopathy. At 42 yr of age the occurrence of central retinal vein occlusion with permanent loss of left eye vision led to the decision to perform bilateral laparoscopic adrenalectomy. Surgery was followed by normalization of blood pressure and good compliance with glucocorticoid and androgen substitutive therapies. In vitro, adrenal cells in culture and isolated mitochondria showed extremely low 11beta-hydroxylase activity. Analysis of adrenal CYP11B1 messenger ribonucleic acid (mRNA) by RT-PCR and sequencing showed the expression of a shorter mRNA that lacked exon 8 and did not contain either the exon 5 mutation or the exon 1 and 2 polymorphisms. This suggested that one CYP11B1 allele carried the intron 8 mutation, responsible for skipping exon 8. The other allele carried the exon 5 mutation, and its mRNA was not detectable. Western blot analysis showed weak expression of a shorter CYP11B immunoreactive band of 43 kDa, consistent with truncation of exon 8. Thus, bilateral adrenalectomy in this patient allowed effective treatment of severe hypertension and helped in understanding the mechanisms and physiopathological consequences of two novel mutations of CYP11B1.


Subject(s)
Adrenal Hyperplasia, Congenital/genetics , Adrenal Hyperplasia, Congenital/surgery , Adrenalectomy , Alternative Splicing , Hypertension/etiology , Mutation , Steroid 11-beta-Hydroxylase/genetics , Adrenal Glands/pathology , Adrenal Hyperplasia, Congenital/pathology , Adrenocorticotropic Hormone/blood , Adult , Base Sequence , Disorders of Sex Development/diagnosis , Disorders of Sex Development/etiology , Exons , Female , Glucocorticoids/blood , Humans , Hypertension/genetics , Laparoscopy , Mineralocorticoids/blood , Renin/blood , Reverse Transcriptase Polymerase Chain Reaction
4.
Thyroid ; 9(5): 483-92, 1999 May.
Article in English | MEDLINE | ID: mdl-10365680

ABSTRACT

This study demonstrates the involvement of a Bax-Bcl2-dependent apoptotic process in Graves-Basedow thyroid disease, a pathological condition known for its spontaneously oscillating evolution. A continuous series of 86 cases of surgically treated Graves' thyroid was evaluated for apoptotic cell content identified by histological criteria and confirmed by terminal desoxynucleotidyl transferase-mediated desoxyuridine triphosphate nick end-labeling (TUNEL). A significant correlation was found between tissue features of Graves' disease (epithelial hyperplasia, cellular hypertrophy, colloid content) and the amount of apoptotic cells. No correlation was found with lymphocytic infiltrates. Significantly, 11 cases (about 12% of the series) with high-level apoptosis displayed the typical features of active Graves' disease over all tissue sections. In contrast, cases with no detectable apoptosis exhibited regressive tissue features of Graves' disease. An intermediate group of cases was characterized by tissue heterogeneity with hyperactive foci, rich in apoptosis, alternating with regressive areas lacking apoptosis. In this group the participation of apoptosis to the remodeling of Graves' thyroid parenchyma, in a tight balance with cell proliferation, was best illustrated. Moreover, the thyroid follicle by accumulating apoptotic cells and bodies, allowed a tentative chronological ordering of apoptosis steps in correlation with Bax-Bcl2 tissue distribution and cellular pattern. Our observations suggest that the initiation of apoptosis corresponds to a loss of cellular cohesion, a drop in Bcl2 expression, and a delocalization of Bax from a putative Golgi storage location to a mitochondrial distribution.


Subject(s)
Apoptosis , Graves Disease/pathology , Proto-Oncogene Proteins c-bcl-2/analysis , Proto-Oncogene Proteins/analysis , Thyroid Gland/pathology , Adult , Colloids/analysis , Graves Disease/classification , Graves Disease/surgery , Humans , Hyperplasia , Hypertrophy , In Situ Nick-End Labeling , Lymphocytes/pathology , bcl-2-Associated X Protein
5.
Ann Pathol ; 19(6): 480-6, 1999 Dec.
Article in French | MEDLINE | ID: mdl-10617804

ABSTRACT

The aim of this study was to compare 64 genetically determined pheochromocytomas (PH) (49 MEN IIa, 3 MEN IIb, 6 Von Recklinghausen diseases, 1 von Hippel-Lindau disease, 5 familial pheochromocytomas) and 48 sporadic PH. Genetically determined PH were more often observed among men and more frequently bilateral and multicentric than sporadic PH. Sporadic tumors had more often adrenal capsular invasion, necrosis and pseudocysts. Genetically determined PH were more differentiated with an insular pattern, hyaline globules and a higher percentage of polyhedric cells. Sporadic tumors were less differentiated with more frequently a diffuse pattern and small cells. Adrenal medullar hyperplasia was significantly associated with genetically determined PH. Adrenal cortical hyperplasia was not associated with a particular type of PH. The PS100 and chromogranin immunodetection was equivalent in both groups.


Subject(s)
Adrenal Gland Neoplasms/genetics , Adrenal Gland Neoplasms/pathology , Pheochromocytoma/genetics , Pheochromocytoma/pathology , Adrenal Cortex/pathology , Adult , Diagnosis, Differential , Female , Humans , Hyperplasia , Male , Multiple Endocrine Neoplasia Type 2a/genetics , Multiple Endocrine Neoplasia Type 2a/pathology , Multiple Endocrine Neoplasia Type 2b/genetics , Multiple Endocrine Neoplasia Type 2b/pathology , Neurofibromatosis 1/genetics , Neurofibromatosis 1/pathology , von Hippel-Lindau Disease/genetics , von Hippel-Lindau Disease/pathology
6.
Arch Anat Cytol Pathol ; 46(1-2): 128-40, 1998.
Article in French | MEDLINE | ID: mdl-9754368

ABSTRACT

This article precises the technical conditions of fine-needle aspiration, elements of microscopical analyses which establish the diagnostic, complementary technics, specially immunocytochemistry that could enhance the performance. Limits and worrisome histologic changes following fine needle aspiration are also discussed. Fine needle aspiration results are discussed. The text is fully illustrated.


Subject(s)
Biopsy, Needle/methods , Thyroid Diseases/pathology , Thyroid Gland/pathology , Thyroid Neoplasms/pathology , Diagnosis, Differential , Humans , Immunohistochemistry , Thyroid Diseases/classification , Thyroid Neoplasms/classification
7.
Biomed Pharmacother ; 52(6): 252-8, 1998.
Article in English | MEDLINE | ID: mdl-9755824

ABSTRACT

In the absence of a universal specific molecular tracer of apoptosis, structural DNA alterations provide the basis of labeling systems: double-strand fragmentation for TUNEL (terminal transferase-mediated dUTP nick end-labeling), denaturation for poly (A) in situ hybridization, immunogenicity of single strand DNA, all methods which imply limited specificity due to the unavoidable presence of DNA breaks in virtually all cells. Thus, TUNEL application has been restrained to a narrow spectrum of sample conditions which has limited, in particular, retrospective surveys and apoptotic nuclei-protein double labelings. In the apoptotic nucleus two main obstacles intervene between TUNEL reagents and their targets: DNA hypercondensation and proteins around DNA. The former increases in the course of apoptosis and both are worsened by crosslinking and precipitating fixatives. This point out that TUNEL is an ambitious approach whose target, apoptotic DNA breaks, is less accessible than breaks occurring in non-apoptotic less compacted DNA. However, TUNEL has an advantage: the far greater degree of apoptotic DNA fragmentation. How to obtain a frank differential staining between apoptotic and non-apoptotic DNA? It appears that the answer relies on the pretreatment step and not in modifying the TUNEL staining protocol, which is optimal. Adapted pretreatments are able to circumvent accessibility obstacles and to extend TUNEL applicability to the most demanding conditions, those of archived tissue samples and of TUNEL--protein double labelings.


Subject(s)
Apoptosis , DNA Fragmentation , DNA/metabolism , Thyroid Gland/pathology , Apoptosis/drug effects , Apoptosis/radiation effects , Coloring Agents , DNA, Neoplasm/metabolism , Dexamethasone/pharmacology , Graves Disease/pathology , Graves Disease/surgery , Histological Techniques , Humans , In Situ Hybridization , Leukemia, T-Cell , Microwaves , Thyroid Gland/physiopathology , Tumor Cells, Cultured
9.
Hum Pathol ; 29(10): 1078-84, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9781645

ABSTRACT

A group of 13 pathologists belonging to the French Calcitonin Tumor Study Group (GETC: Groupe d'Etude des Tumeurs à Calcitonine) examined the histological slides and medical records of 109 proband cases of medullary thyroid carcinoma (MTC) diagnosed on clinical features. The cases belonged to the various forms of the disease (80 sporadic and 29 familial MTC). The aim of the study was to detect histological predictors for survival by comparing morphological data from patients killed by the disease versus the others. Twenty-seven histological parameters were considered, including cellular heterogeneity, shape of the cells, and cytoplasmic characteristics. Other parameters such as sex, age, and phenotype of the disease were also studied. First, predictive parameters of interest on survival function were selected by univariate analysis (Mantel-Cox test). Then, the extracted parameters were tested in a multifactorial analysis using the Cox's forward stepping proportional hazard model. Five parameters were significantly associated with a lower survival function: presence of necrosis in the tumor (P = .001), squamous pattern (P = .002), age over 45 years (P = .004), presence of oxyphil cells in the tumor and absence of cells with intermediate cytoplasm (P = .025), less than 50% of calcitonin immunoreactive cells in the tumor (P = .04).


Subject(s)
Carcinoma, Medullary/mortality , Carcinoma, Medullary/pathology , Thyroid Neoplasms/mortality , Thyroid Neoplasms/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Child , Female , Humans , Male , Middle Aged , Retrospective Studies , Survival Analysis
10.
J Clin Endocrinol Metab ; 83(9): 3134-43, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9745416

ABSTRACT

We studied a patient with food-induced, ACTH-independent, Cushing's syndrome and a unilateral adrenocortical adenoma. In vivo cortisol secretion was stimulated by mixed, glucidic, lipidic, or proteic meals. Plasma ACTH levels were undetectable, but iv injection of ACTH stimulated cortisol secretion. Unilateral adrenalectomy was followed by hypocortisolism with loss of steroidogenic responses to both food and ACTH. In vitro, cortisol secretion by isolated tumor cells was stimulated by the gut hormone gastric inhibitory polypeptide (GIP) and ACTH, but not by another gut hormone, glucagon-like peptide-1 (GLP-1). Both peptides stimulated the production of cAMP but not of inositol 1,4,5-trisphosphate. In quiescent cells, GIP and ACTH stimulated [3H]thymidine incorporation and p42-p44 mitogen-activated protein kinase activity. GIP receptor messenger ribonucleic acid (RNA), assessed by RT-PCR, was highly expressed in the tumor, whereas it was undetectable in the adjacent hypotrophic adrenal tissue, in two adrenal tumors responsible for food-independent Cushing's syndrome, and in two hyperplastic adrenals associated with ACTH hypersecretion. In situ hybridization demonstrated that expression of GIP receptor RNA was confined to the adrenocortical tumor cells. Low levels of ACTH receptor messenger RNA were also detectable in the tumor. We conclude that abnormal expression of the GIP receptor allows adrenocortical cells to respond to food intake with an increase in cAMP that may participate in the stimulation of both cortisol secretion and proliferation of the tumor cells.


Subject(s)
Adenoma/complications , Adrenal Cortex Neoplasms/complications , Cushing Syndrome/etiology , Gastric Inhibitory Polypeptide/pharmacology , Adenoma/metabolism , Adenoma/surgery , Adrenal Cortex Neoplasms/metabolism , Adrenal Cortex Neoplasms/surgery , Adrenalectomy , Adrenocorticotropic Hormone/pharmacology , Adult , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , DNA/biosynthesis , Female , Gene Expression , Glucagon/pharmacology , Glucagon-Like Peptide 1 , Humans , Hydrocortisone/blood , Hydrocortisone/metabolism , Peptide Fragments/pharmacology , Polymerase Chain Reaction , Protein Precursors/pharmacology , RNA, Messenger/analysis , Receptors, Corticotropin/genetics , Receptors, Gastrointestinal Hormone/genetics , Tumor Cells, Cultured
11.
J Histochem Cytochem ; 46(3): 327-34, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9487114

ABSTRACT

TUNEL, i.e., terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling, has become a widely used staining method to assist in detection of apoptotic cells in tissue sections. However, despite its apparent simplicity, this technique has led to considerable disappointment because of its serious limitations in sensitivity and, even more, in specificity. We reviewed the limitations and artifacts of TUNEL and designed a comprehensive protocol to reassess the various procedures in use for five crosslinking and/or precipitating fixatives. By introducing microwave heating in extreme pH-value solutions (pH 3 for formalin and pH 10.6 for Bouin's fixative) coupled with proteolysis, we obtained an intense staining of 70-80% of apoptotic cells and bodies on archival tissue blocks, with little or no background. Owing to the enhanced sensitivity, early stages of apoptosis could be visualized and may enlarge our vision of the apoptotic cell beyond the mere image of shrinkage necrosis. We conclude that TUNEL remains a technique as useful as it is delicate, requiring critical interpretation of the staining. This study points out that, on archival tissues, despite the technical improvements we propose no protocol can be the final answer to all problems. Technique must be readjusted for any variation in tissue processing. However, step-by-step progress has rendered this method not only applicable but also performable within the constraints of archival surgical pathology specimens.


Subject(s)
Apoptosis , Histocytochemistry/methods , Histocytological Preparation Techniques , Graves Disease/pathology , Humans , Hydrogen-Ion Concentration , Microwaves , Prospective Studies , Retrospective Studies
12.
J Clin Endocrinol Metab ; 82(10): 3487-92, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9329390

ABSTRACT

We describe a large multigenerational multiple endocrine neoplasia Type 1 (MEN1) family with clinical expression suggestive of anticipation. In the second and third generations, two deceased obligate gene carriers died at the ages of 85 and 76 without the history of MEN1, whereas two other living gene carriers above the age of 65 have had no clinical evidence of MEN1 to date. In the fourth generation, eight members were affected, with four having severe MEN1-related and atypical malignancies: a case of metastatic endocrine pancreatic tumor, two cases of metastatic thymic carcinoids, and a case of spinal ependymoma. In the fifth generation, all five patients were below the age of 22 when the disease was detected. MEN1 was confirmed in the family by linkage analysis using MEN1-linked microsatellite markers and by identification of a nonsense mutation in the MEN1/menin gene. Alleotyping showed loss of heterozygosity (LOH) involving the wild-type alleles in seven tumors in the family including the ependymoma, which is the first MEN1-related case that shows genetic abnormality in chromosome 11q13, suggesting that MEN1 gene might be involved in the tumorigenesis of a subset of ependymomas. In relation to clinical anticipation, repeated expansion studies were carried out but failed to detect any expansion. We conclude that this is a unique MEN1 family and that an unknown genetic mechanism might be contributing to the anticipation phenomenon. We demonstrate in this family that all gene carriers, including the very young members, will need close and careful follow-up.


Subject(s)
Multiple Endocrine Neoplasia Type 1/genetics , Adult , Age of Onset , Aged , Alleles , Cytogenetics , Disease Progression , Female , Genetic Linkage , Germ-Line Mutation , Heterozygote , Humans , Loss of Heterozygosity , Male , Middle Aged , Multiple Endocrine Neoplasia Type 1/epidemiology , Multiple Endocrine Neoplasia Type 1/physiopathology , Pedigree
13.
Gene Ther ; 3(11): 1010-7, 1996 Nov.
Article in English | MEDLINE | ID: mdl-9044741

ABSTRACT

Cationic amphiphiles have been shown to mediate gene transfer to eukaryotic cells, although the nature and fate of the lipid-DNA complexes is still a matter of debate. Negative staining transmission electron microscopy (TEM) of the complexes in physiological medium, as well as thin-section TEM of transfected cells has been used to visualize the particles and the possible pathways leading to transgene expression. Lipopolyamines form a network of tubular micelles into which plasmid DNA is intertwined and condensed; the cationic particles contain hundreds of plasmid molecules and are heterogeneous with respect to size (0.1-0.5 microgram) and shape. Adherent cells (293M, 3T3, MRC5, primary leptomeningeal cells) take them up readily within minutes by spontaneous endocytosis. Among suspension cells, lymphocytes only incidentally show cytoplasmic inclusions and monocytes degrade the particles by phagocytosis. The marked decrease in transfection efficiency generally observed between adherent and nonadherent cells is thus due to reduce cell binding. This suggests that cationic particles bind to membrane components responsible for Ca2+-mediated cell anchoring to the extracellular matrix. Cation/anion-mediated endocytosis leads to endosomes that are entirely filled with the particles. Consequently, two escape mechanisms may operate: disruption of the lamellar envelope in close contact with tubular micelles, and endosome buffering by the lipopolyamine in response to proton entry, leading to osmotic swelling and endosome rupture. Even for moderately transfected MRC5 cells, 10(2)-10(3) particles are found either free or in cytoplasmic vacuoles 24 h after transfection, highlighting a very inefficient nuclear translocation process. Such high numbers are also the clue to the small concentration window between transfection and cytotoxicity that is often observed with nonviral vectors. Nuclear particle inclusions are sometimes seen, yet it is unclear whether plasmid uncoating (before expression) takes place by anion exchange in the cytoplasm or in the nucleus. The still lower efficiency of free plasmid translocation to the nucleus suggests an active role for the cationic lipid during this step. Although the last stages of the transfection mechanism remain unclear, the present work shows that the major barrier which hampers in vitro gene delivery with cationic vectors is nuclear translocation (and cell entry for nonadherent cells), providing precise targets for the design of improved nonviral vectors.


Subject(s)
Gene Transfer Techniques , Microscopy, Electron , Plasmids , Polyamines , 3T3 Cells , Animals , Cell Nucleus , Cells, Cultured , Endocytosis , Humans , Mice , Tumor Cells, Cultured
14.
J Histochem Cytochem ; 44(9): 959-68, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8773561

ABSTRACT

TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling) is a method of choice for rapid identification and quantification of the apoptotic cell fraction in cultured cell preparations. However, TUNEL application has been restricted to a narrow spectrum of sample conditions, and only detergents have been proposed as labeling enhancers. This study was aimed at extending TUNEL to variously fixed cells and improving TUNEL sensitivity by optimized pretreatments, the specificity being assessed by reference to the apoptotic morphology. Comparative TUNEL was performed with three protocols on CEM-C7 cells, a model of glucocorticoid-induced apoptosis. Samples were submitted to six modalities of fixation and TUNEL was performed after each of the following conditions: no pretreatment; detergent permeabilization; proteolytic digestion; microwave irradiation; and a recently published combination of the latter two. The proportion of TUNEL-stained elements within the cell fraction, with and without apoptotic morphology, was quantified. Our results showed that: (a) with an adequate pretreatment, reliable TUNEL can be obtained after each fixative tested; (b) detergent was inefficient in improving sensitivity; (c) whatever the fixation, microwave pretreatment provided the best TUNEL sensitivity without notable loss of specificity; (d) under adaptive technical conditions, TUNEL can be associated with detection of various proteins by double labeling; and (e) the existence of a limited population of intensely TUNEL-positive cells that lacked apoptotic morphology contributes to the current debate about a preapoptotic state.


Subject(s)
Apoptosis , In Situ Hybridization/methods , Tissue Fixation/methods , Cell Size , Detergents/metabolism , Evaluation Studies as Topic , Humans , Microwaves , Peptide Hydrolases/metabolism , Sensitivity and Specificity , Tumor Cells, Cultured
15.
J Histochem Cytochem ; 44(7): 665-71, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8675987

ABSTRACT

For in situ hybridization (ISH), development of sensitive, nontoxic alternatives to the use of radioactivity is a constant concern. In this trend, and close to chromogenes and fluorophores, chemiluminescence appears an attractive method. A first positive experience in immunocytochemistry and in ISH, by using the enhanced luminol as luminogene substrate for horseradish peroxidase (HRP) led us to compare the sensitivity of 35S autoradiography and chemiluminescence. For this purpose, we used three human carcinoma cell lines, CaSki [400-600 copies of human papilloma virus (HPV) 16], HeLa (10-50 copies of HPV 18), and SiHa (1-5 copies of HPV 16), and 40 biopsy specimens of human cervical preneoplastic and neoplastic lesions. We performed ISH by using HPV cDNA biotin-labeled probes, detected by a two-step immunocytochemical reaction, the secondary antibodies being either 35S-labeled for autoradiography or HRP-labeled for chemiluminescence. An intensified CCD camera allowed acquisition of the luminescent signal. After only 10 min of photon accumulation, on cell line smears as well as on serial tissue sections, chemiluminescence gave comparable results to those obtained by a 3-week exposure for 35S autoradiography. A quantitative approach on cervical biopsy specimens confirmed this similar level of sensitivity by measuring the area of 35S- or chemiluminescence-stained nuclei. Our results indicate that chemiluminescence is a credible and perfectible alternative to radioisotopes for in situ detection of nucleic acids by hybridization.


Subject(s)
DNA, Viral/analysis , Papillomaviridae/isolation & purification , Uterine Cervical Dysplasia/virology , Biopsy , HeLa Cells , Humans , In Situ Hybridization , Luminescent Measurements , Papillomaviridae/genetics , Sulfur Radioisotopes , Tumor Cells, Cultured , Uterine Cervical Dysplasia/pathology
16.
J Biolumin Chemilumin ; 10(4): 247-56, 1995.
Article in English | MEDLINE | ID: mdl-8533606

ABSTRACT

Bio- and chemiluminescence have proved sensitive enough to compete with chromogenic and radioisotopic tracers for in situ detection. However, they must also provide a discriminant morphological analysis of the specific signal. We have tested seven bio- or chemiluminescent reagents for tissue antigen and nucleic acid detection by immunocytochemistry (ICC) or in situ hybridization (ISH). They were based on luminescent detection of peroxidase, alkaline phosphatase, beta-galactosidase or xanthine oxidase. We also explored whether high molecular weight polymers could increase the spatial definition of the photon emission. An ICCD camera was used to collect the light signal provided by immunolabelling of endothelial cells and by ISH of human papilloma virus on cell smears. Among the enzyme-luminescent substrate combinations tested, the enhanced luminol chemiluminescence (ECL) gave the best resolution of the specific signal. The other systems were mainly hampered by a high diffusion of the reaction product over the tissue section. Unfortunately, in this case, the high molecular weight polymers tested were inefficient. However, the addition of polyvinylalcohol (PVA) or polyvinylpyrrolidone (PVP) significantly improved respectively the definition and intensity of ECL photon emission. We demonstrate that chemiluminescence gives a morphological resolution allowing histological examination. The extension of this new application, now depends on physicochemical adaptation of chemiluminescent reagents to the constraints of tissue detection.


Subject(s)
Antigens/analysis , Luminescent Measurements , Nucleic Acids/analysis , Cell Line , Humans , Immunohistochemistry , In Situ Hybridization , Indicators and Reagents , Nucleic Acids/genetics , Papillomaviridae/genetics , Polymers , Thyroid Gland/immunology
17.
Mol Cell Endocrinol ; 110(1-2): 175-84, 1995 Apr 28.
Article in English | MEDLINE | ID: mdl-7672447

ABSTRACT

The aim of this study was to evaluate the occurrence and physiological consequences of apoptosis in primary cultures of bovine adrenocortical cells (of fasciculata-reticularis origin). Under ACTH-free culture conditions, we observed apoptotic cells in the cell layer and the accumulation of apoptotic bodies in the culture medium. These were hardly detectable in ACTH-supplemented cultures. Under ACTH-free conditions, the DNA content of apoptotic bodies collected over 48 h represented up to 10-15% of that of the cell layer at the onset of the culture (as compared to 3% in ACTH-supplemented cultures). Past the fourth day of culture in the absence of ACTh, most cells lacked several markers of their originating fasciculata-reticularis phenotype and progressively evolved to an undifferentiated phenotype. The vast majority of the apoptotic bodies released during the first 4 days of culture were immunoreactive for P450 17 alpha. Inversely, during the same period of time, the proliferating cells (PCNA-positive) did not appear to express P450 17 alpha. Therefore, apoptosis could contribute, together with dedifferentiation, to the phenotype shift observed in ACTH-depleted cultures of adrenal fasciculata-reticularis cells. These observations also characterize this endocrine cell system as an in vitro model for the study of hormone-repressed apoptosis.


Subject(s)
Adrenal Cortex/cytology , Apoptosis , Adrenal Cortex/drug effects , Adrenal Cortex/metabolism , Adrenocorticotropic Hormone/administration & dosage , Adrenocorticotropic Hormone/pharmacology , Animals , Cattle , Cell Count , Cell Differentiation , Cells, Cultured , Chromatin/ultrastructure , Cytochrome P-450 CYP11B2 , Cytochrome P-450 Enzyme System/metabolism , DNA/metabolism , Microscopy, Electron , Phenotype , Steroid 11-beta-Hydroxylase/metabolism
18.
Ann Endocrinol (Paris) ; 56(6): 620-4, 1995.
Article in French | MEDLINE | ID: mdl-8787356

ABSTRACT

Patients with Cushing's disease are not cured by transsphenoidal microsurgery in about 30% of the cases. Beside the problem of invasive macroadenomas, these failures are due either to diagnostic errors, or to very small microadenomas that could no be found. Positive diagnosis of hypercortisolism is quite straightforward and the problem is sensitivity rather than specificity. Primary adrenocortical hypercortisolism should not be mistaken. Depression-related hypercortisolism can be difficult to distinguish from Cushing disease: most cases are recognized after clinical story and CRF stimulation test. Ectopic ACTH secretion by a carcinoid tumor represents at least 8% of ACTH-dependant hypercortisolism. It cannot be reliably distinguished from corticotroph microadenoma by either classical dynamic tests or anterior pituitary imaging. However measurements of ACTH in the inferior petrosal sinus under basal condition and CRF stimulation allow the diagnosis of central or peripheral ACTH secretion with a quasi 100% sensitivity and specificity. In contrast this technique is of poor help for the diagnosis of lateralization of corticotroph microadenomas, for which it gives erroneous results in 25 to 50% of the cases. Rapid intraoperative measurement of ACTH in peripituitary blood seems a more reliable approach. In our series it gave correct results in 11 out of 12 cases. In 1995 hormonal exploration of Cushing disease should limit the failures of anterior pituitary surgery to the cases of invasive macroadenomas that cannot be completely removed.


Subject(s)
Adrenocorticotropic Hormone/metabolism , Cushing Syndrome/surgery , Hydrocortisone/metabolism , Pituitary Gland, Anterior/surgery , Postoperative Complications/metabolism , Cushing Syndrome/complications , Humans , Petrosal Sinus Sampling/adverse effects , Pituitary Neoplasms/complications , Postoperative Complications/etiology
19.
Surg Neurol ; 42(6): 481-8, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7825102

ABSTRACT

Inflammatory pseudotumors (IPT) are rare lesions composed of inflammatory cells admixed with collagen tissue. Although IPT are ubiquitous, intracranial locations are rare. In this study, four intracranial IPT of the plasma-cell-granuloma (PCG) type are reported. Four patients presented with lesions located, respectively, in the right cavernous sinus, the left cavernous sinus with extension to the tentorium cerebelli, the vermis cerebelli, and the pituitary stalk. All patients were operated on, but complete resection could not be achieved in cases 1 and 2. Follow-up was favorable in all cases, although case 1 still complained of headaches 2 years after operation. All cases were studied on histologic and immunohistochemical bases, and ultrastructural analysis was performed on two cases. In cases 1, 2, and 4, IPT were made up of plasma cells admixed with lymphocytes and rare histiocytes in a fibrous tissue-the density of which varied from case to case. In case 3, the mass was composed of plasma cells associated with numerous foamy histiocytes and polymorphonuclear cells. No light chain restriction could be demonstrated when immunohistochemistry was performed, and ultrastructural study did not disclose features reminiscent of meningioma or histiocytosis X. Intracranial IPT should not be confused with other diseases such as meningioma, lymphoproliferative disorders, or histiocytosis X. Although intracranial locations are much rarer than pulmonary ones, histology is identical in both sites and shows different patterns in its evolution. This is in agreement with the inflammatory origin of this lesion.


Subject(s)
Brain Diseases/pathology , Granuloma, Plasma Cell/pathology , Adult , Child , Female , Humans , Male , Middle Aged
20.
Mol Cell Endocrinol ; 105(2): 155-63, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7532142

ABSTRACT

We previously identified alpha 2-macroglobulin as the major protein secreted by primary cultures of adrenocortical cells. We report here that in the adrenal gland, the distribution of alpha 2-macroglobulin in the adrenocortical tissue is restricted to the endothelium of blood vessels and that no immunoreactivity is found in steroidogenic cells. A time course study revealed that freshly dissociated bovine adrenocortical cells were void of alpha 2-macroglobulin immunoreactivity whereas the proportion of alpha 2-macroglobulin-positive cells reached more than two-thirds of the population between day 4 and day 7 of culture. Double immunoenzymatic labeling of 6-day-old cultures revealed a co-localization of alpha 2-macroglobulin and the steroidogenic enzyme P-450SCC. Treatment of 5-day-old cultures (expressing alpha 2-macroglobulin) for 24 h by either ACTH (10(-9)-10(-6) M) or alpha 2-macroglobulin (2.5 mg/ml) resulted in a marked decrease of the expression of alpha 2-macroglobulin. These data indicate that ACTH and plasmatic alpha 2-macroglobulin could physiologically repress alpha 2-macroglobulin expression in the adrenal cortex in vivo.


Subject(s)
Adrenal Cortex/cytology , Adrenal Cortex/metabolism , alpha-Macroglobulins/biosynthesis , Adrenal Cortex/blood supply , Adrenal Cortex/chemistry , Adrenocorticotropic Hormone/pharmacology , Animals , Cattle , Cells, Cultured , Cholesterol Side-Chain Cleavage Enzyme/analysis , Cholesterol Side-Chain Cleavage Enzyme/metabolism , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Humans , Immunohistochemistry , Time Factors , alpha-Macroglobulins/analysis , alpha-Macroglobulins/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...